Both Amphetamine and Kenalog offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Kenalog is gentler on the liver and kidneys and has a better safety profile for long-term use, particularly for older patients or those with pre-existing conditions.

Amphetamine has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Kenalog offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Both Amphetamine and Kenalog have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Amphetamine is great for fast relief, while Kenalog is better for long-term management. The choice depends on the patient’s specific needs.